van der Tol, Arjan Lameire, Norbert Morton, Rachael L Van Biesen, Wim Vanholder, Raymond
Background and objectives: The prevalence of patients with ESKD who receive extracorporeal kidney replacement therapy is rising worldwide. We compared government reimbursement for hemodialysis and peritoneal dialysis worldwide, assessed the effect on the government health care budget, and discussed strategies to reduce the cost of kidney replacemen...
Snauwaert, Evelien VandeWalle, Johan Nagler, Evi V. Van Biesen, Wim
Published in
Pediatric Nephrology
Evidence-based medicine (EBM) is gaining importance in the current paediatric healthcare landscape. Improvement of paediatric health status is its major aim. However, for EBM to be successful, all stakeholders involved should understand what EBM really is, why and how EBM should or should not be practiced, and have the necessary skills to distingui...
Walker, Rachael C Walker, Shayne Morton, Rachael L Tong, Allison Howard, Kirsten Palmer, Suetonia C
Published in
BMJ open
To explore and describe Māori (the indigenous people of New Zealand) patients' experiences and perspectives of chronic kidney disease (CKD), as these are largely unknown for indigenous groups with CKD. Face-to-face, semistructured interviews with purposive sampling and thematic analysis. 3 dialysis centres in New Zealand (NZ), all of which offered ...
Schmidt, Morten Mansfield, Kathryn E Bhaskaran, Krishnan Nitsch, Dorothea Sørensen, Henrik Toft Smeeth, Liam Tomlinson, Laurie A
Published in
BMJ open
Only one-tenth of patients initiating ACEI/ARB therapy receive the guideline-recommended creatinine monitoring. Moreover, the vast majority of the patients fulfilling postinitiation discontinuation criteria for creatinine and potassium increases continue on treatment.
Nistor, Ionut Bolignano, Davide Haller, Maria C Nagler, Evi van der Veer, Sabine N Jager, Kitty Covic, Adrian Webster, Angela Van Biesen, Wim
Chronic kidney disease (CKD) is common and is associated with increased mortality, morbidity and cost. However, insufficient high-quality trial data are available to answer many relevant clinical questions in this field. In addition, a wide range of variable outcomes are used in studies, and often they are incompletely reported. Furthermore, there ...
Wesseling, Catharina Aragón, Aurora González, Marvin Weiss, Ilana Glaser, Jason Rivard, Christopher J Roncal-Jiménez, Carlos Correa-Rotter, Ricardo Johnson, Richard J
Published in
BMJ open
To study Mesoamerican nephropathy (MeN) and its risk factors in three hot occupations. Cross-sectional. Chinandega and León municipalities, a MeN hotspot on the Nicaraguan Pacific coast, January-February 2013. 194 male workers aged 17-39 years: 86 sugarcane cutters, 56 construction workers, 52 small-scale farmers. (1) Differences between the three ...
Keng, Li-Ta Tsou, Ping-Hsien
Published in
Postgraduate medical journal
Hoste, Eric De Loor, Jorien
The 0by25 Global Snapshot sheds light on the recognition, management and outcomes of acute kidney injury (AKI) in countries worldwide stratified by gross national income. These novel epidemiological data open new horizons for preventing death from AKI particularly in developing countries.
Helldén, Anders Al-Aieshy, Fadiea Bastholm-Rahmner, Pia Bergman, Ulf Gustafsson, Lars L Höök, Hans Sjöviker, Susanne Söderström, Anders Odar-Cederlöf, Ingegerd
Published in
BMJ open
To assess general practitioners (GPs) experience from the implementation and use of a renal computerised decision support system (CDSS) for drug dosing, developed for primary healthcare, integrated into the patient's electronic health record (EHR), and building on estimation of the patient's creatinine clearance (ClCG). Qualitative research design ...
Wong, Jonathan Jeraj, Hassan Vilar, Enric Viljoen, Adie Farrington, Ken
Published in
Journal of clinical pathology
The kinetic LAL turbidimetric assay is a valid tool for the detection of blood endotoxin in patients with ESKD, although in blood specimens with low-level endotoxemia (≤0.05 EU/mL) the assay may be less accurate and precise. Tween 80 can be used as a diluent to optimise recovery of endotoxin in ESKD plasma.